PEDIATRICS Vol. 114 No. 6 December 2004, pp. 1739-1740 (doi:10.1542/peds.2004-1626)
Findings From Selective Serotonin Reuptake InhibitorExposed Neonates Should Be Interpreted With Caution
Jonathan D. Norton, MSDepartment of Biostatistics
Linda L. M. Worley, MD
Departments of Psychiatry and Obstetrics and Gynecology
Curtis L. Lowery, MD
Department of Obstetrics and Gynecology
University of Arkansas for Medical Sciences
Little Rock, AR 72212
| The first 20% of the full text of this article appears below. |
To the Editor.
After reading the noteworthy Zeskind and Stephens1 study of the effects of in utero exposure to selective serotonin reuptake inhibitors (SSRIs) on neonates, it is likely that many obstetricians will consider whether to alter treatment of their depressed patients. We hope that readers will
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
E. L. Moses-Kolko, D. Bogen, J. Perel, A. Bregar, K. Uhl, B. Levin, and K. L. Wisner Neonatal Signs After Late In Utero Exposure to Serotonin Reuptake Inhibitors: Literature Review and Implications for Clinical Applications JAMA, May 18, 2005; 293(19): 2372 - 2383. [Abstract] [Full Text] [PDF] |
||||





